Circulating monocytes from patients with MS secrete more pro-inflammatory (e.g., IL-6 and IL-12) cytokines and express more co-stimulatory molecules, a phenotype favoring proinflammatory T-cell responses (17, 18). This evidence concerns the gene IL6 and myeloid sarcoma.